Alnylam Pharmaceuticals Inc (ALNY)
147.50
+4.19
(+2.92%)
USD |
NASDAQ |
Apr 29, 14:58
Alnylam Pharmaceuticals Shares Outstanding: 125.95M for Feb. 9, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 09, 2024 | 125.95M |
December 31, 2023 | 125.79M |
October 27, 2023 | 125.49M |
September 30, 2023 | 125.45M |
July 28, 2023 | 125.00M |
June 30, 2023 | 124.90M |
April 28, 2023 | 124.53M |
March 31, 2023 | 124.24M |
March 24, 2023 | 124.22M |
February 17, 2023 | 124.13M |
January 31, 2023 | 123.92M |
December 31, 2022 | 123.92M |
October 21, 2022 | 123.03M |
September 30, 2022 | 122.99M |
July 22, 2022 | 120.03M |
June 30, 2022 | 120.99M |
April 22, 2022 | 120.81M |
March 31, 2022 | 120.73M |
March 28, 2022 | 120.72M |
February 04, 2022 | 120.21M |
January 31, 2022 | 120.20M |
December 31, 2021 | 120.18M |
October 22, 2021 | 119.60M |
September 30, 2021 | 119.48M |
July 30, 2021 | 118.85M |
Date | Value |
---|---|
June 30, 2021 | 118.60M |
April 23, 2021 | 117.54M |
March 31, 2021 | 117.32M |
March 29, 2021 | 117.32M |
February 05, 2021 | 117.00M |
January 31, 2021 | 116.99M |
December 31, 2020 | 116.43M |
October 30, 2020 | 116.18M |
September 30, 2020 | 116.14M |
July 31, 2020 | 115.97M |
June 30, 2020 | 115.65M |
April 30, 2020 | 114.82M |
April 10, 2020 | 114.04M |
March 31, 2020 | 113.17M |
March 09, 2020 | 113.07M |
February 07, 2020 | 112.58M |
January 31, 2020 | 112.44M |
December 31, 2019 | 112.19M |
October 25, 2019 | 111.49M |
September 30, 2019 | 111.32M |
July 31, 2019 | 111.21M |
June 30, 2019 | 111.11M |
April 30, 2019 | 106.54M |
April 08, 2019 | 106.44M |
March 31, 2019 | 106.40M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
106.54M
Minimum
Apr 30 2019
125.95M
Maximum
Feb 09 2024
118.64M
Average
119.16M
Median
Shares Outstanding Benchmarks
Ionis Pharmaceuticals Inc | 145.75M |
Pfizer Inc | 5.647B |
Blueprint Medicines Corp | 61.23M |
Madrigal Pharmaceuticals Inc | 19.90M |
Sarepta Therapeutics Inc | 93.86M |